Scott Martin's Biography

Scott Martin, Group Leader, RNAi Screening, NCATS, NIH

Dr. Martin is the leader of RNAi Screening at the NIH Center for Advancing Translational Sciences (NCATS), NIH. His facility performs numerous genome-wide RNAi screens in collaboration with NIH intramural investigators. These studies span a wide variety of biology, ranging from cancer to infectious and rare diseases. Dr. Martin is not only interested in discoveries made through RNAi screening, but also advancing its successful application. His group is also engaged in exploring new technologies and strategies for the understanding of gene function. Prior to establishing the RNAi Screening Facility at NIH, Dr. Martin attained is Ph.D in chemistry at The Pennsylvania State University in 2004. While there, his studies focused on engineering small molecules for the targeted delivery of bioactive cargo to the surface of cancer cells. After obtaining his Ph.D., Dr. Martin pursued a postdoctoral fellowship at the National Cancer Institute (NCI) in Bethesda to further his understanding of cancer biology. At NCI, Dr. Martin’s work focused on understanding RNA interference (RNAi) in mammalian cells, and using RNAi as a tool to uncover genes associated with cancer and the activity of therapeutically relative agents.